Cite
Prophylaxis with Lamivudine of Hepatitis B Virus Reactivation in Chronic HbsAg Carriers with Hemato-oncological Neoplasias Treated with Chemotherapy.
MLA
Rossi, Giuseppe. “Prophylaxis with Lamivudine of Hepatitis B Virus Reactivation in Chronic HbsAg Carriers with Hemato-Oncological Neoplasias Treated with Chemotherapy.” Leukemia & Lymphoma, vol. 44, no. 5, May 2003, p. 759. EBSCOhost, https://doi.org/10.1080/104281903100006351.
APA
Rossi, G. (2003). Prophylaxis with Lamivudine of Hepatitis B Virus Reactivation in Chronic HbsAg Carriers with Hemato-oncological Neoplasias Treated with Chemotherapy. Leukemia & Lymphoma, 44(5), 759. https://doi.org/10.1080/104281903100006351
Chicago
Rossi, Giuseppe. 2003. “Prophylaxis with Lamivudine of Hepatitis B Virus Reactivation in Chronic HbsAg Carriers with Hemato-Oncological Neoplasias Treated with Chemotherapy.” Leukemia & Lymphoma 44 (5): 759. doi:10.1080/104281903100006351.